Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Development of more efficacious Tc-99m organ imaging agents for use in nuclear medicine by analytical characterization of radiopharmaceutical mixtures. Progress report, May 1, 1982-April 30, 1983

Technical Report ·
OSTI ID:6607725
A procedure based on high performance liquid chromatography (HPLC) has been developed for separating individual Tc-diphosphonate complexes in skeletal-imaging radiopharmaceuticals prepared by reduction of TcO/sub 4//sup -/ with NaBH/sub 4/ in the presence of methylene diphosphonate (MDP). Seven different Tc-MDP complexes have been detected and isolated in pure form. Significant differences in skeletal uptake and blood clearance are exhibited by the three complexes tested thus far by biodistribution studies in test animals. The relative quantities of these complexes present in a radiopharmaceutical preparation are dramatically influenced by the pH of the reaction mixture. Thus, control of pH is a simple means of forming in high yield the single, most efficacious Tc-MDP complex for skeletal imaginG. An HPLC method with electrochemical detection has been developed for the analytical determination of total TcO/sub 4//sup -/ (/sup 99m/Tc + /sup 99/Tc). Concentrations of TcO/sub 4//sup -/ as low as 9 x 10/sup -9/ M can be detected. The method is being evaluated for monitoring total TcO/sub 4//sup -/ in /sup 99/Mo//sup 99m/Tc generators.
Research Organization:
Cincinnati Univ., OH (USA)
DOE Contract Number:
AC02-80EV10380
OSTI ID:
6607725
Report Number(s):
DOE/EV/10380-3; ON: DE83002767
Country of Publication:
United States
Language:
English